Bridging Scales in Alzheimer's Disease: Biological Framework for Brain Simulation With The Virtual Brain
Despite the acceleration of knowledge and data accumulation in neuroscience over the last years, the highly prevalent neurodegenerative disease of AD remains a growing problem. Alzheimer's Disease (AD) is the most common cause of dementia and represents the most prevalent neurodegenerative dise...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Neuroinformatics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fninf.2021.630172/full |
id |
doaj-91d465ae934b4aef9c34f85b6e878928 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Leon Stefanovski Leon Stefanovski Jil Mona Meier Jil Mona Meier Roopa Kalsank Pai Roopa Kalsank Pai Roopa Kalsank Pai Paul Triebkorn Paul Triebkorn Paul Triebkorn Tristram Lett Tristram Lett Leon Martin Leon Martin Konstantin Bülau Konstantin Bülau Martin Hofmann-Apitius Ana Solodkin Anthony Randal McIntosh Petra Ritter Petra Ritter Petra Ritter Petra Ritter Petra Ritter |
spellingShingle |
Leon Stefanovski Leon Stefanovski Jil Mona Meier Jil Mona Meier Roopa Kalsank Pai Roopa Kalsank Pai Roopa Kalsank Pai Paul Triebkorn Paul Triebkorn Paul Triebkorn Tristram Lett Tristram Lett Leon Martin Leon Martin Konstantin Bülau Konstantin Bülau Martin Hofmann-Apitius Ana Solodkin Anthony Randal McIntosh Petra Ritter Petra Ritter Petra Ritter Petra Ritter Petra Ritter Bridging Scales in Alzheimer's Disease: Biological Framework for Brain Simulation With The Virtual Brain Frontiers in Neuroinformatics Alzheimer's disease The Virtual Brain brain simulation multi-scale brain modeling connectomics |
author_facet |
Leon Stefanovski Leon Stefanovski Jil Mona Meier Jil Mona Meier Roopa Kalsank Pai Roopa Kalsank Pai Roopa Kalsank Pai Paul Triebkorn Paul Triebkorn Paul Triebkorn Tristram Lett Tristram Lett Leon Martin Leon Martin Konstantin Bülau Konstantin Bülau Martin Hofmann-Apitius Ana Solodkin Anthony Randal McIntosh Petra Ritter Petra Ritter Petra Ritter Petra Ritter Petra Ritter |
author_sort |
Leon Stefanovski |
title |
Bridging Scales in Alzheimer's Disease: Biological Framework for Brain Simulation With The Virtual Brain |
title_short |
Bridging Scales in Alzheimer's Disease: Biological Framework for Brain Simulation With The Virtual Brain |
title_full |
Bridging Scales in Alzheimer's Disease: Biological Framework for Brain Simulation With The Virtual Brain |
title_fullStr |
Bridging Scales in Alzheimer's Disease: Biological Framework for Brain Simulation With The Virtual Brain |
title_full_unstemmed |
Bridging Scales in Alzheimer's Disease: Biological Framework for Brain Simulation With The Virtual Brain |
title_sort |
bridging scales in alzheimer's disease: biological framework for brain simulation with the virtual brain |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Neuroinformatics |
issn |
1662-5196 |
publishDate |
2021-04-01 |
description |
Despite the acceleration of knowledge and data accumulation in neuroscience over the last years, the highly prevalent neurodegenerative disease of AD remains a growing problem. Alzheimer's Disease (AD) is the most common cause of dementia and represents the most prevalent neurodegenerative disease. For AD, disease-modifying treatments are presently lacking, and the understanding of disease mechanisms continues to be incomplete. In the present review, we discuss candidate contributing factors leading to AD, and evaluate novel computational brain simulation methods to further disentangle their potential roles. We first present an overview of existing computational models for AD that aim to provide a mechanistic understanding of the disease. Next, we outline the potential to link molecular aspects of neurodegeneration in AD with large-scale brain network modeling using The Virtual Brain (www.thevirtualbrain.org), an open-source, multiscale, whole-brain simulation neuroinformatics platform. Finally, we discuss how this methodological approach may contribute to the understanding, improved diagnostics, and treatment optimization of AD. |
topic |
Alzheimer's disease The Virtual Brain brain simulation multi-scale brain modeling connectomics |
url |
https://www.frontiersin.org/articles/10.3389/fninf.2021.630172/full |
work_keys_str_mv |
AT leonstefanovski bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT leonstefanovski bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT jilmonameier bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT jilmonameier bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT roopakalsankpai bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT roopakalsankpai bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT roopakalsankpai bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT paultriebkorn bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT paultriebkorn bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT paultriebkorn bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT tristramlett bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT tristramlett bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT leonmartin bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT leonmartin bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT konstantinbulau bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT konstantinbulau bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT martinhofmannapitius bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT anasolodkin bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT anthonyrandalmcintosh bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT petraritter bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT petraritter bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT petraritter bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT petraritter bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain AT petraritter bridgingscalesinalzheimersdiseasebiologicalframeworkforbrainsimulationwiththevirtualbrain |
_version_ |
1724176762417446912 |
spelling |
doaj-91d465ae934b4aef9c34f85b6e8789282021-04-01T07:25:40ZengFrontiers Media S.A.Frontiers in Neuroinformatics1662-51962021-04-011510.3389/fninf.2021.630172630172Bridging Scales in Alzheimer's Disease: Biological Framework for Brain Simulation With The Virtual BrainLeon Stefanovski0Leon Stefanovski1Jil Mona Meier2Jil Mona Meier3Roopa Kalsank Pai4Roopa Kalsank Pai5Roopa Kalsank Pai6Paul Triebkorn7Paul Triebkorn8Paul Triebkorn9Tristram Lett10Tristram Lett11Leon Martin12Leon Martin13Konstantin Bülau14Konstantin Bülau15Martin Hofmann-Apitius16Ana Solodkin17Anthony Randal McIntosh18Petra Ritter19Petra Ritter20Petra Ritter21Petra Ritter22Petra Ritter23Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, GermanyCharité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurology with Experimental Neurology, Brain Simulation Section, Berlin, GermanyBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, GermanyCharité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurology with Experimental Neurology, Brain Simulation Section, Berlin, GermanyBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, GermanyCharité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurology with Experimental Neurology, Brain Simulation Section, Berlin, GermanyBernstein Center for Computational Neuroscience Berlin, Berlin, GermanyBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, GermanyCharité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurology with Experimental Neurology, Brain Simulation Section, Berlin, GermanyInstitut de Neurosciences des Systèmes, Aix Marseille Université, Marseille, FranceBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, GermanyCharité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurology with Experimental Neurology, Brain Simulation Section, Berlin, GermanyBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, GermanyCharité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurology with Experimental Neurology, Brain Simulation Section, Berlin, GermanyBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, GermanyCharité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurology with Experimental Neurology, Brain Simulation Section, Berlin, GermanyFraunhofer Institute for Algorithms and Scientific Computing SCAI, Sankt Augustin, GermanyBehavioral and Brain Sciences, University of Texas at Dallas, Dallas, TX, United StatesBaycrest Health Sciences, Rotman Research Institute, Toronto, ON, CanadaBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, GermanyCharité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurology with Experimental Neurology, Brain Simulation Section, Berlin, GermanyBernstein Center for Computational Neuroscience Berlin, Berlin, GermanyEinstein Center for Neuroscience Berlin, Berlin, GermanyEinstein Center Digital Future, Berlin, GermanyDespite the acceleration of knowledge and data accumulation in neuroscience over the last years, the highly prevalent neurodegenerative disease of AD remains a growing problem. Alzheimer's Disease (AD) is the most common cause of dementia and represents the most prevalent neurodegenerative disease. For AD, disease-modifying treatments are presently lacking, and the understanding of disease mechanisms continues to be incomplete. In the present review, we discuss candidate contributing factors leading to AD, and evaluate novel computational brain simulation methods to further disentangle their potential roles. We first present an overview of existing computational models for AD that aim to provide a mechanistic understanding of the disease. Next, we outline the potential to link molecular aspects of neurodegeneration in AD with large-scale brain network modeling using The Virtual Brain (www.thevirtualbrain.org), an open-source, multiscale, whole-brain simulation neuroinformatics platform. Finally, we discuss how this methodological approach may contribute to the understanding, improved diagnostics, and treatment optimization of AD.https://www.frontiersin.org/articles/10.3389/fninf.2021.630172/fullAlzheimer's diseaseThe Virtual Brainbrain simulationmulti-scale brain modelingconnectomics |